Persistent
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma (NCT06781073) | Biotech Pharmaceutical Co., Ltd. | 2017-07-06 |
Track Persistent automatically
Every clearance here is in the API, with alerts when new ones post.